EM2487, a novel anti-HIV-1 antibiotic, produced by Streptomyces sp. Mer-2487: taxonomy, fermentation, biological properties, isolation and structure elucidation

J Antibiot (Tokyo). 1999 Nov;52(11):971-82. doi: 10.7164/antibiotics.52.971.

Abstract

For the purpose of discovering novel agents that inhibit HIV-1 replication at the transcriptional level, we have established cell lines reflecting the HIV-1 long terminal repeat-driven gene expression. Using these cell lines, we have screened approximately 10,000 microorganism products and found that the culture supernatant of Streptomyces sp. Mer-2487 suppresses the HIV-1 Tat-induced gene expression without affecting the basal or tumor necrosis factor-alpha-induced transcription. The purified active component has a unique structure, as shown in Fig. 1. This compound has an inhibitory effect on HIV-1 replication in chronically infected cells as well as acutely infected cells, suggesting that the inhibition occurs at a postintegration step of HIV-1 proviral DNA in the HIV-1 replication cycle.

MeSH terms

  • Anti-Bacterial Agents / isolation & purification*
  • Anti-HIV Agents / isolation & purification*
  • Cell Line
  • Fermentation
  • HIV-1 / drug effects*
  • HIV-1 / genetics
  • HIV-1 / physiology
  • Humans
  • Organophosphates / chemistry
  • Organophosphates / isolation & purification*
  • Organophosphates / pharmacology
  • Streptomyces / classification*
  • Streptomyces / metabolism
  • Uridine / analogs & derivatives*
  • Uridine / chemistry
  • Uridine / isolation & purification
  • Uridine / pharmacology
  • Virus Replication / drug effects

Substances

  • Anti-Bacterial Agents
  • Anti-HIV Agents
  • EM 2487
  • Organophosphates
  • Uridine